These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28395279)

  • 1. Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease.
    Csencsits-Smith K; Suescun J; Li K; Luo S; Bick DL; Schiess M
    Neuroimmunomodulation; 2016; 23(5-6):301-308. PubMed ID: 28395279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients.
    Rydbirk R; Elfving B; Andersen MD; Langbøl MA; Folke J; Winge K; Pakkenberg B; Brudek T; Aznar S
    Neurobiol Dis; 2017 Oct; 106():269-278. PubMed ID: 28732710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
    Goldstein DS; Kopin IJ; Sharabi Y; Holmes C
    Clin Auton Res; 2015 Feb; 25(1):61-7. PubMed ID: 25638582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study.
    Compta Y; Dias SP; Giraldo DM; Pérez-Soriano A; Muñoz E; Saura J; Fernández M; Bravo P; Cámara A; Pulido-Salgado M; Painous C; Ríos J; Martí MJ;
    Parkinsonism Relat Disord; 2019 Aug; 65():3-12. PubMed ID: 31178335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes.
    Lee JH; Kim TH; Mun CW; Kim TH; Han YH
    J Neurol; 2015 Aug; 262(8):1876-82. PubMed ID: 26016683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy.
    Brisinda D; Sorbo AR; Di Giacopo R; Venuti A; Bentivoglio AR; Fenici R
    J Neurol Sci; 2014 Jan; 336(1-2):197-202. PubMed ID: 24267739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.
    Lee PH; Lee G; Park HJ; Bang OY; Joo IS; Huh K
    J Neural Transm (Vienna); 2006 Oct; 113(10):1435-9. PubMed ID: 16465458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm.
    Bhattacharya K; Saadia D; Eisenkraft B; Yahr M; Olanow W; Drayer B; Kaufmann H
    Arch Neurol; 2002 May; 59(5):835-42. PubMed ID: 12020268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Bukhatwa S; Zeng BY; Rose S; Jenner P
    Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
    Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage.
    Baschieri F; Calandra-Buonaura G; Doria A; Mastrolilli F; Palareti A; Barletta G; Solieri L; Guaraldi P; Martinelli P; Cortelli P
    Parkinsonism Relat Disord; 2015 May; 21(5):477-82. PubMed ID: 25749354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy.
    Kaufman E; Hall S; Surova Y; Widner H; Hansson O; Lindqvist D
    PLoS One; 2013; 8(4):e62354. PubMed ID: 23626805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor activation in multiple system atrophy and Parkinson disease: a PET study.
    Payoux P; Brefel-Courbon C; Ory-Magne F; Regragui W; Thalamas C; Balduyck S; Durif F; Azulay JP; Tison F; Blin O; Esquerre JP; Rascol O
    Neurology; 2010 Sep; 75(13):1174-80. PubMed ID: 20876470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
    Vogt IR; Lees AJ; Evert BO; Klockgether T; Bonin M; Wüllner U
    Exp Neurol; 2006 Jun; 199(2):465-78. PubMed ID: 16626704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
    Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intracranial volume in Parkinson's disease.
    Krabbe K; Karlsborg M; Hansen A; Werdelin L; Mehlsen J; Larsson HB; Paulson OB
    J Neurol Sci; 2005 Dec; 239(1):45-52. PubMed ID: 16225890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.